The structural determinants responsible for c-Fos protein proteasomal degradation differ according to the conditions of expression

Oncogene

Volumn 22, Issue 10, 2003, Pages 1461-1474

  Ferrara, Patrizia ^a   Andermarcher, Elisabetta ^a   Bossis, Guillaume ^a   Acquaviva, Claire ^a,b   Brockly, Frédérique ^a   Jariel Encontre, Isabelle ^a   Piechaczyk, Marc ^a  

^a CNRS   (France)

^b WELLCOME CRC INSTITUTE   (United Kingdom)

Author keywords

c Fos; Proteasome; Protein degradation

Indexed keywords

CELL DNA; LEUCINE ZIPPER PROTEIN; PROTEIN C FOS; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL TYPE; COMPLEX FORMATION; CONTROLLED STUDY; DIMERIZATION; DNA SEQUENCE; EMBRYO; EMBRYO CELL; ENZYME DEGRADATION; FIBROBLAST; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GENE STRUCTURE; HALF LIFE TIME; MOUSE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY;

ANIMALS; CELL DIVISION; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; EMBRYO; EPIDERMAL GROWTH FACTOR; FIBROBLASTS; G1 PHASE; GENE EXPRESSION REGULATION; GENES, REPORTER; HALF-LIFE; MICE; MICE, INBRED BALB C; MULTIENZYME COMPLEXES; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RECOMBINANT PROTEINS; SEQUENCE DELETION; SERINE;

ANIMALIA;

EID: 0037435037     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206266     Document Type: Article

References (71)

1. Abate C, Luk D and Curran T. (1990). Cell Growth Diff., 1, 455-462.
2. Acquaviva C, Brockly F, Ferrara P, Bossis G, Salvat C, Jariel-Encontre I and Piechaczyk M. (2001a). Oncogene, 20, 7563-7572.
3. Acquaviva C, Salvat C, Brockly F, Bossis G, Ferrara P, Piechaczyk M and Jariel-Encontre I. (2001b). Oncogene, 20, 7563-7572.
4. Angel P, Szabowski A and Schorpp-Kistner M. (2001). Oncogene, 20, 2413-2423.
5. Bakiri L, Matsuo K, Wisniewska M, Wagner EF and Yaniv M. (2002). Mol. Cell. Biol., 22, 4952-4964.
6. Chaussepied M, Lallemand D, Moreau MF, Adamson R, Hall R and Langsley G. (1998). Mol. Biochem. Parasitol., 94, 215-226.
7. Chen J, Kelz MB, Hope BT, Nakabeppu Y and Nestler EJ. (1997). J. Neurosci., 17, 4933-4941.
8. Chen RH, Abate C and Blenis J. (1993). Proc. Natl. Acad. Sci. USA, 90, 10952-10956.
9. Chen RH, Juo PC, Curran T and Blenis J. (1996). Oncogene, 12, 1493-1502.
10. Chinenov Y and Kerppola TK. (2001). Oncogene, 20, 2438-2452.
11. Coux O. (2002). Prog. Mol. Subcell Biol., 29, 85-107.
12. Curran T. (1988). The Oncogene Handbook. Elsevier: Amsterdam, pp 307-325.
13. DeMartino GN and Slaughter CA. (1999). J. Biol. Chem., 274, 22123-22126.
14. Dobrazanski P, Noguchi T, Kovary K, Rizzo CA, Lazo PS and Bravo R. (1991). Mol. Cell Biol., 11, 5470-5478.
15. Eibl B, Greiter E, Grunewald K, Gastl G, Weyrer K, Thaler J, Aulitzky W, Herrmann F, Rapp U and Huber C. (1995). Cytokines Mol. Ther., 1, 29-38.
16. Ferdous A, Gonzalez F, Sun L, Kodadek T and Johnston SA. (2001). Mol. Cell, 7, 981-991.
17. Fujii M, Niki T, Mori T, Matsuda T, Matsui M, Nomura N and Seiki M. (1991). Oncogene, 6, 1023-1029.
18. Gamberi G, Benassi MS, Bohling T, Ragazzini P, Molendini L, Sollazzo MR, Pompetti F, Merli M, Magagnoli G, Balladelli A and Picci P. (1998). Oncology, 55, 556-563.
19. Gianni M, Bauer A, Garattini E, Chambon P and Rochette-Egly C. (2002). EMBO J., 21, 3760-3769.
20. Glickman MH and Ciechanover A. (2002). Physiol. Rev., 82, 373-428.
21. Gonzalez F, Delahodde A, Kodadek T and Johnston SA. (2002). Science, 296, 548-550.
22. Gruda MC, Kovary K, Metz R and Bravo R. (1994). Oncogene, 9, 2537-2547.
23. Hafezi F, Steinbach JP, Marti A, Munz K, Wang ZQ, Wagner EF, Aguzzi A and Reme CE. (1997). Nat. Med., 3, 346-349.
24. He H, Qi XM, Grossmann J and Distelhorst CW. (1998). J. Biol. Chem., 273, 25015-25019.
25. Herdegen T and Waetzig V. (2001). Oncogene, 20, 2424-2437.
26. Hermida-Matsumoto ML, Chock PB, Curran T and Yang DC. (1996). J. Biol. Chem., 271, 4930-4936.
27. Huang TS, Kuo ML, Lin JK and Hsieh JS. (1995). Cancer Lett., 96, 1-7.
28. Iwahashi M, Otsuka M, Shimotakahara S, Uozumi K, Hanada S, Arima T and Matsumoto M. (1994). Br. J. Haematol., 86, 193-194.
29. Jochum W, Passegue E and Wagner EF. (2001). Oncogene, 20, 2401-2412.
30. Johnson RS, Spiegelman BM and Papaioannou V. (1992). Cell, 71, 577-586.
31. Kanaitsuka T, Ishii K, Zu Y, Ashihara T, Hanaoka M and Namba Y. (1988). Acta. Pathol. Jpn., 38, 1523-1536.
32. Kanaitsuka T, Itani K, Shigeta H, Yamamura Y, Kogawa T, Yoshikawa T, Sugino S, Kanatsuna T, Kondou M, Takashina K. (1987). Nippon Naika Gakkai Zasshi, 76, 1595-1603.
33. Kim YH, Choi MR, Song DK, Huh SO, Jang CG and Suh HW. (2000). Brain Res., 872, 227-230.
34. Kisselev AF and Goldberg AL. (2001). Chem. Biol., 8, 739-758.
35. Kovary K and Bravo R. (1991). Mol. Cell. Biol., 11, 2451-2459.
36. Kovary K and Bravo R. (1992). Mol. Cell. Biol., 12, 5015-5023.
37. Krappmann D, Wulczyn FG and Scheidereit C. (1996). EMBO J., 15, 6716-6726.
38. Lallemand D, Spyrou G, Yaniv M and Pfarr CM. (1997). Oncogene, 14, 819-830.
39. Li X, Zhao X, Fang Y, Jiang X, Duong T, Fan C, Huang CC and Kain SR. (1998). J. Biol. Chem., 273, 34970-34975.
40. Macian F, Lopez-Rodriguez C and Rao A. (2001). Oncogene, 20, 2476-2489.
41. Malek NP, Sundberg H, McGrew S, Nakayama K, Kyriakides TR, Roberts JM and Kyriakidis TR. (2001). Nature, 413, 323-327.
42. Masson N, Willam C, Maxwell PH, Pugh CW and Ratcliffe PJ. (2001). EMBO J., 20, 5197-5206.
43. Masuyama H and MacDonald PN. (1998). J. Cell Biochem., 71, 429-440.
44. Miao GG and Curran T. (1994). Mol. Cell. Biol., 14, 4295-4310.
45. Navon A and Goldberg AL. (2001). Mol. Cell, 8, 1339-1349.
46. Okazaki K and Sagata N. (1995). EMBO J., 14, 5048-5059.
47. Papavassiliou AG, Treier M, Chavrier C and Bohmann D. (1992). Science, 258, 1941-1944.
48. Perkins G, Drury LS and Diffley JF. (2001). EMBO J., 20, 4836-4845.
49. Pickart CM. (2001). Annu. Rev. Biochem., 70, 503-533.
50. Piechaczyk M and Blanchard JM. (1994). Crit. Rev. Oncol. Hematol., 17, 93-131.
51. Ransone LJ, Visvader J, Wamsley P and Verma IM. (1990). Proc. Natl. Acad. Sci. USA, 87, 3806-3810
52. Rech J and Fort P. (1989). Nucleic Acids Res., 17, 2874.
53. Rechsteiner M and Rogers SW. (1996). Trends Biochem. Sci., 21, 267-271.
54. Rogers S, Wells R and Rechsteiner M. (1986). Science, 234, 364-368.
55. Roux P, Blanchard JM, Fernandez A, Lamb N, Jeanteur P and Piechaczyk M. (1990). Cell, 63, 341-351
56. Rubio N, Rojo P and Torres C. (1996). J. Neurovirol., 2, 167-174.
57. Salvat C, Jariel-Encontre I, Acquaviva C, Omura S and Piechaczyk M. (1998). Oncogene, 17, 327-337.
58. Sambrook J, Fritsch EF and Maniatis T. (1989). Molecular cloning Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY.
59. Schreiber M, Baumann B, Cotten M, Angel P and Wagner EF. (1995). EMBO J., 14, 5338-5349.
60. Schuermann M, Neuberg M, Hunter JB, Jenuwein T, Ryseck RP, Bravo R and Muller R. (1989). Cell, 56, 507-516.
61. Shaulian E and Karin M. (2001). Oncogene, 20, 2390-2400.
62. Stancovski I, Gonen H, Orian A, Schwartz AL and Ciechan-over A. (1995). Mol. Cell. Biol., 15, 7106-7116
63. Su K, Yang X, Roos MD, Paterson AJ and Kudlow JE. (2000). Biochem. J., 348 (Part 2), 281-289.
64. Tajima S and Aida Y. (2002). J. Virol., 76, 2557-2562.
65. Tansey WP. (2001). Genes Dev., 15, 1045-1050.
66. Thomas D and Tyers M. (2000). Curr. Biol., 10, R341-R343.
67. Tsurumi C, Ishida N, Tamura T, Kakizuka A, Nishida E, Okumura E, Kishimoto T, Inagaki M, Okazaki K, Sagata N et al. (1995). Mol. Cell. Biol., 15, 5682-5687.
68. van Dam H and Castellazzi M. (2001). Oncogene, 20, 2453-2464.
69. Wang W, Chevray PM and Nathans D. (1996). Proc. Natl. Acad. Sci. USA, 93, 8236-8240.
70. Wang ZQ, Ovitt C, Grigoriadis AE, Mohle-Steinlein U, Ruther U and Wagner EF. (1992). Nature 360, 741-745
71. Zhang J, Zhang D, McQuade JS, Behbehani M, Tsien JZ and Xu M. (2002). Nat. Genet., 30, 416-420.